MAPT and Alzheimer disease: A plethora of studies has found close associations among AD, cognitive impairment, the tau/Aβ ratio, APOE4 positive status, white matter hyperintensities, and atrophy in specific brain regions, and these may serve as potential diagnostic biomarkers of AD in the future (22, 35–40).